Rare diseases
Investigational molecules
Locations
Back to Spain546 clinical trials in Zaragoza, Spain across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Study on Atezolizumab for Patients with Lung and Liver Cancer Using Digital Health Solutions
SpainStudy of Bemarituzumab and Chemotherapy for Patients with Advanced Stomach or Gastroesophageal Cancer with FGFR2b Overexpression
SpainStudy on Adding Apalutamide to Radiotherapy and LHRH Agonist for High-Risk Patients with Hormone-Sensitive Prostate Cancer
SpainStudy of Nivolumab for Patients with Liver Cancer at High Risk of Recurrence After Surgery or Ablation
SpainStudy on the Effectiveness of Autogene Cevumeran in Patients with ctDNA Positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer
SpainStudy of ALX148 with Trastuzumab, Ramucirumab, and Paclitaxel for Patients with Advanced Gastric or Gastroesophageal Junction Cancer
SpainStudy of Nivolumab and Ipilimumab for Patients with Advanced Liver Cancer (Hepatocellular Carcinoma) as First-Line Treatment
SpainStudy of Daratumumab with Drug Combination for Patients with Newly Diagnosed Multiple Myeloma Eligible for High-Dose Therapy
SpainStudy of Ravulizumab for Adults with Lupus Nephritis or IgA Nephropathy
SpainStudy of Datopotamab Deruxtecan and Durvalumab for Adults with Untreated Triple-Negative or Hormone Receptor-Low/HER2-Negative Breast Cancer
SpainStudy on Atezolizumab and Trastuzumab Emtansine for Patients with HER2-Positive Breast Cancer at High Risk of Recurrence After Preoperative Therapy
SpainStudy on Olaparib for Patients with High-Risk HER2-Negative Breast Cancer and BRCA1/2 Mutations After Chemotherapy
SpainThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on advanced cancer treatments and blood disorders, including studies of new therapies for lung cancer, pancreatic adenocarcinoma, and various hematologic malignancies.
Multiple trials evaluating combination therapies and novel treatment approaches for both solid tumors and blood cancers.
Research into treatments for various inflammatory and autoimmune disorders, with emphasis on chronic conditions affecting quality of life.
Studies focusing on innovative biological therapies and targeted treatments for inflammatory conditions.
Studies addressing critical cardiovascular health challenges and metabolic conditions, including innovative approaches to stroke treatment and lipid management.
Focus on developing new therapeutic options for both acute and chronic cardiovascular conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
